Susquehanna International Group
XERS icon

Susquehanna International Group’s Xeris Biopharma Holdings XERS Stock Holding History

Susquehanna International Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Buy
53,100
+30,900
+139% +$205K ﹤0.01% 10797
2025
Q4 		$174K Buy
22,200
+7,500
+51% +$59K ﹤0.01% 11026
2025
Q3 		$120K Buy
14,700
+3,400
+30% +$22.6K ﹤0.01% 11455
2025
Q2 		$52.8K Sell
11,300
-2,300
-17% -$10.5K ﹤0.01% 12093
2025
Q1 		$74.7K Buy
+13,600
New +$54.9K ﹤0.01% 11711
2023
Q4 		– Sell
-11,100
Closed -$20.6K – 13420
2023
Q3 		$20.6K Sell
11,100
-7,000
-39% -$16K ﹤0.01% 11591
2023
Q2 		$47.4K Buy
+18,100
New +$46.1K ﹤0.01% 11361
2022
Q4 		– Sell
-41,700
Closed -$65K – 13837
2022
Q3 		$65K Sell
41,700
-17,600
-30% -$29.1K ﹤0.01% 12039
2022
Q2 		$91K Sell
59,300
-5,700
-9% -$12K ﹤0.01% 11554
2022
Q1 		$166K Sell
65,000
-26,500
-29% -$64.7K ﹤0.01% 11462
2021
Q4 		$268K Buy
91,500
+34,900
+62% +$75.4K ﹤0.01% 10757
2021
Q3 		$139K Sell
56,600
-52,200
-48% -$152K ﹤0.01% 11847
2021
Q2 		$443K Buy
108,800
+61,100
+128% +$233K ﹤0.01% 9876
2021
Q1 		$215K Buy
47,700
+2,100
+5% +$11.3K ﹤0.01% 11301
2020
Q4 		$224K Buy
45,600
+13,900
+44% +$69.5K ﹤0.01% 9854
2020
Q3 		$188K Buy
+31,700
New +$127K ﹤0.01% 9505

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's XERS Position: Q1 2026 in Review

Susquehanna International Group increased its Xeris Biopharma Holdings (XERS) stake by 144% in Q1 2026, buying an estimated $1.12M and bringing the position to 286,071 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #6604.

Susquehanna International Group first reported a position in XERS in Q2 2019 and has held it in 25 quarters since. The position peaked at $3.5M in Q1 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Susquehanna International Group held 286,071 shares of Xeris Biopharma Holdings worth $1.66M as of Q1 2026.
  • Susquehanna International Group bought 168,716 Xeris Biopharma Holdings shares in Q1 2026, an estimated $1.12M.
  • Xeris Biopharma Holdings made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6604 holding.
  • Susquehanna International Group first reported a position in Xeris Biopharma Holdings in Q2 2019 and has held it in 25 quarters since.
  • Susquehanna International Group's Xeris Biopharma Holdings position peaked at $3.5M in Q1 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.